BiomeSense

BiomeSense

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://www.biomesense.com/

Last Round

Seed

Oct 20, 2025

Total Funding Raised

$13.73M

Company Overview

BiomeSense is a healthtech company that provides an integrated precision measurement and analytics platform designed to transform microbiome data generation and analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

gut microbiome analysislongitudinal microbiome datamicrobiome data platformAI-enabled bioinformaticsbiomarker discoverycontinuous sample collectionat-home biosensorsmart toilet sensorbioinformatics platformclinical research toolspersonalized medicinegut health techsequencing servicesmicrobiome therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BiomeSense Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BiomeSense Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedOct 20, 2025
GrantMar 15, 2024
SeedMay 18, 2023
SeedOct 7, 2019
AcceleratorMar 28, 2019
Grant
Jun 6, 2018

Key People

Founding team and executive leadership

Kevin Honaker

CEO

Executive Team

BiomeSense Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 20, 2025

    $7M round led by Bluestein Ventures.

  • May 3, 2025

    Monthly visitors grew 92% MoM, reaching 2.5K.

BiomeSense Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BiomeSense Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BiomeSense's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range17
Year Founded2018
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.